Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/29/2012US20120076848 Method and system for effecting changes in pigmented tissue
03/29/2012US20120076847 Medical instrument and method of manufacturing the same
03/29/2012US20120076837 Surface engineering of tissue graft materials for enhanced porosity and cell adhesion
03/29/2012US20120076809 Method to inhibit the biological activity of calcineurin with selective peptides
03/29/2012US20120076805 Methods and Compositions for the Generation and Maintenance of Regulatory T Cells
03/29/2012US20120076785 Method for inhibiting neurodegeneration
03/29/2012US20120076779 STABILIZATION OF IMMUNOGLOBULINS AND OTHER PROTEINS THROUGH AQUEOUS FORMULATIONS WITH SODIUM CHLORIDE AT WEAK ACIDIC TO NEUTRAL ph
03/29/2012US20120076774 Detection and/or treatment of diseases associated with autoantibodies
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076771 Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials
03/29/2012US20120076769 Herbal composition for cancer treatment
03/29/2012US20120076768 Digestive/laxative compositions
03/29/2012US20120076767 Process for concentration of a polypeptide
03/29/2012US20120076764 Methods and pharmaceutical compositions for healing wounds
03/29/2012US20120076758 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/29/2012US20120076757 Composition for transmucosal delivery of polypeptides
03/29/2012US20120076756 Novel benzimidazole derivatives
03/29/2012US20120076755 Hepatitis C Virus Inhibitors
03/29/2012US20120076754 Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis
03/29/2012US20120076753 Use of nkp46 for preventing diabetes
03/29/2012US20120076752 Mesothelin Vaccines and Model Systems
03/29/2012US20120076742 Topical drug delivery system with dual carriers
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012US20120076729 Methods of treating cancers
03/29/2012US20120076728 Human protein scaffold with controlled serum pharmacokinetics
03/29/2012US20120076724 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
03/29/2012US20120076723 Devices and methods for the treatment of cancer
03/29/2012US20120076722 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression
03/29/2012CA2849382A1 Therapeutic applications of smad7
03/29/2012CA2813049A1 Modified compstatin with improved stability and binding properties
03/29/2012CA2812999A1 Composition comprising sod, lutein and zeaxanthin
03/29/2012CA2812704A1 Formulations for bovine granulocyte colony stimulating factor and variants thereof
03/29/2012CA2812416A1 Human b1 cells and uses thereof
03/29/2012CA2812261A1 Macrocyclic proline derived hcv serine protease inhibitors
03/29/2012CA2811957A1 Novel immunostimulatory method
03/29/2012CA2811797A1 Mosquitocidal xenorhabdus, lipopeptide and methods
03/29/2012CA2811734A1 Multimeric il-15 soluble fusion molecules and methods of making and using same
03/29/2012CA2811654A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
03/28/2012EP2434288A1 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure
03/28/2012EP2434287A1 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure
03/28/2012EP2434282A2 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
03/28/2012EP2434022A2 Use of A33 antigens and JAM-IT
03/28/2012EP2434014A1 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
03/28/2012EP2434008A1 Laccases for pulp bio-bleaching
03/28/2012EP2433963A1 Receptor (SSTR2)-selective somatostatin antagonists
03/28/2012EP2433653A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
03/28/2012EP2433647A2 GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
03/28/2012EP2433643A1 Medicaments comprising triptan and botulinum toxin for use in treating headache
03/28/2012EP2433642A2 Modified proteases that inhibit complement activation
03/28/2012EP2433641A1 Obligate heterodimer meganucleases and uses thereof
03/28/2012EP2433639A2 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
03/28/2012EP2433623A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
03/28/2012EP2433622A1 Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
03/28/2012EP2433618A1 Easy-disintegrating polymeric micelle composition
03/28/2012EP2432874A1 Extracellular yaluronidase from streptomyces koganeiensis
03/28/2012EP2432802A1 Bifunctional polypeptides
03/28/2012EP2432778A1 Process for the preparation of ibodutant (men15596) and related intermediates
03/28/2012EP2432505A1 Combinations of immunostimulatory agents, oncolytic virus, and additional anticancer therapy
03/28/2012EP2432497A1 Use of lipoprotein lipase (lpl) in therapy
03/28/2012EP2432496A1 Control of uric acid homeostasis
03/28/2012EP2432495A2 Elastin for soft tissue augmentation
03/28/2012EP2432494A2 Peptide
03/28/2012EP2432493A1 Use of il-17 polypeptides for use in the prevention or treatment of atherosclerosis
03/28/2012EP2432492A2 Application and uses of prg4 and therapeutic modulation thereof
03/28/2012EP2432491A2 Means and methods for counteracting polyq expansion disorders
03/28/2012EP2432490A1 Bone morphogenetic proteins for the treatment of insulin resistance
03/28/2012EP2432489A2 Variants of c-type natriuretic peptide
03/28/2012EP2432488A2 Selective and potent peptide inhibitors of kv1.3
03/28/2012EP2432487A1 Inhibition of prion protein propagation by receptor associated protein (rap). its derivatives, mimetics and synthetic peptides
03/28/2012EP2432479A1 Extended acting oxygen generating composition for treating microbial infections
03/28/2012EP2432467A1 Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
03/28/2012EP2432455A2 Composition comprising oil drops
03/28/2012EP2432318A1 Bimacrocyclic hcv ns3 protease inhibitors
03/28/2012EP2337580B1 Stabilized compositions for recombinantly produced factor viii
03/28/2012EP2112999B1 Non-natural recombinant gelatins with enhanced functionality
03/28/2012EP2095825B8 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
03/28/2012EP2021033B1 Il-1-alpha for use in a method of treatment of atherosclerotic plaques.
03/28/2012EP1988915B1 Tumstatin for the treatment of conditions associated with airway tissue remodeling
03/28/2012EP1978990B1 Compositions comprising igbpma and uses thereof
03/28/2012EP1807065B1 Methods and compositions for treating nephrogenic diabetes insipidus
03/28/2012EP1771196B1 Ccr ligands for stem cell homing
03/28/2012EP1766077B1 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
03/28/2012EP1765362B1 Compositions and methods for treatment of neovascular diseases
03/28/2012EP1690870B1 Marker peptide for alzheimer's disease
03/28/2012EP1651667B1 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
03/28/2012EP1569676B1 Calcitonin drug-oligomer conjugates, and uses thereof
03/28/2012EP1392866B1 Novel method for cloning variable domain sequences of immunological gene repertoire
03/28/2012EP1283851B1 Use of il-4r antibodies and compositions thereof
03/28/2012EP1181318B2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
03/28/2012EP1117689B1 Bone morphogenetic protein antagonists based on the mature protein
03/28/2012EP1117684B1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
03/28/2012EP1098909B1 Hybrid human/rodent igg antibody to cd3, and methods of its construction
03/28/2012CN1931874B Preparation process, medicine preparation and medicinal use of ginseng glycopeptide
03/28/2012CN1871024B Remedy and therapeutic method for periodontal diseases and pulpal diseases
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN102395599A Modifications of cupredoxin derived peptides and methods of use thereof
03/28/2012CN102395379A New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor
03/28/2012CN102395377A Muscle function enhancing peptide
03/28/2012CN102395376A Lipid metabolism-improving agent
03/28/2012CN102395375A Apolipoprotein a-i mimics
1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 3163